Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, K.
Right arrow Articles by Baba, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, K.
Right arrow Articles by Baba, A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:1155-1162, 2003
© 2003 by the American Diabetes Association, Inc.

Overexpression of PACAP in Transgenic Mouse Pancreatic ß-Cells Enhances Insulin Secretion and Ameliorates Streptozotocin-induced Diabetes

Kyohei Yamamoto1, Hitoshi Hashimoto1, Shuhei Tomimoto1, Norihito Shintani1, Jun-ichi Miyazaki2, Fumi Tashiro2, Hiroyuki Aihara2, Takao Nammo3, Ming Li3, Kazuya Yamagata3, Jun-ichiro Miyagawa3, Yuji Matsuzawa3, Yuki Kawabata1, Yuji Fukuyama1, Kazumi Koga1, Wakaba Mori1, Kazuhiro Tanaka1, Toshio Matsuda4, and Akemichi Baba1,5

1 Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
2 Division of Stem Cell Regulation Research, Osaka University Medical School, Osaka, Japan
3 Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan
4 Laboratory of Medicinal Pharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
5 Laboratory of Molecular Pharmacology, Osaka University Medical School, Suita, Osaka, Japan

Pituitary adenylate cyclase-activating polypeptide (PACAP), a member of the vasoactive intestinal peptide/secretin/glucagon family, stimulates insulin secretion from islets in a glucose-dependent manner at femtomolar concentrations. To assess PACAP’s pancreatic function in vivo, we generated transgenic mice overexpressing PACAP in the pancreas under the control of human insulin promoter. Northern blot and immunohistochemical analyses showed that PACAP is overexpressed in pancreatic islets, specifically in transgenic mice. Plasma glucose and glucagon levels during a glucose tolerance test were not different between PACAP transgenic mice and nontransgenic littermates. However, plasma insulin levels in transgenic mice were higher after glucose loading. Also, increases of streptozotocin-induced plasma glucose were attenuated in transgenic compared with nontransgenic mice. Notably, an increase in 5-bromo-2-deoxyuridine-positive ß-cells in the streptozotocin-treated transgenic mice was observed but without differences in the staining patterns by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling. Morphometric analysis revealed that total islet mass tends to increase in 12-month-old transgenic mice but showed no difference between 12-week-old transgenic and nontransgenic littermates. This is the first time that PACAP has been observed to play an important role in the proliferation of ß-cells.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. S. Qader, J. Jimenez-Feltstrom, M. Ekelund, I. Lundquist, and A. Salehi
Expression of islet inducible nitric oxide synthase and inhibition of glucose-stimulated insulin release after long-term lipid infusion in the rat is counteracted by PACAP27
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1447 - E1455.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. Ahren, N. Wierup, and F. Sundler
Neuropeptides and the Regulation of Islet Function
Diabetes, December 1, 2006; 55(Supplement_2): S98 - S107.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
H. HASHIMOTO, N. SHINTANI, and A. BABA
New Insights into the Central PACAPergic System from the Phenotypes in PACAP- and PACAP Receptor-Knockout Mice
Ann. N.Y. Acad. Sci., July 1, 2006; 1070(1): 75 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Chen, J.-h. Ding, R. Bekeredjian, B.-z. Yang, R. V. Shohet, S. A. Johnston, H. E. Hohmeier, C. B. Newgard, and P. A. Grayburn
Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology
PNAS, May 30, 2006; 103(22): 8469 - 8474.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. Tsunekawa, Y. Miura, N. Yamamoto, Y. Itoh, Y. Ariyoshi, T. Senda, Y. Oiso, and I. Niki
Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice
Eur. J. Endocrinol., May 1, 2005; 152(5): 805 - 811.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Tomimoto, H. Hashimoto, N. Shintani, K. Yamamoto, Y. Kawabata, K.-I. Hamagami, K. Yamagata, J.-I. Miyagawa, and A. Baba
Overexpression of Pituitary Adenylate Cyclase-Activating Polypeptide in Islets Inhibits Hyperinsulinemia and Islet Hyperplasia in Agouti Yellow Mice
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 796 - 803.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.